Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
November 27 2017 - 4:40PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number:
000-33283
The Advisory Board Company
(Exact name of registrant as specified in its charter)
|
c/o UnitedHealth Group Incorporated
9900 Bren Road East
Minnetonka, MN 55343
Telephone Number:
(952) 936-1300
|
(Address, including zip code, and telephone number, including area code, of registrants principal
executive offices)
Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
Rule 12g-4(a)(2)
|
|
☐
|
Rule
12h-3(b)(1)(i)
|
|
☒
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
Rule
15d-6
|
|
☐
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, The Advisory Board Company has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
The Advisory Board Company
|
|
|
|
Date: November 27, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Robert W. Musslewhite
|
|
|
|
|
Name:
|
|
Robert W. Musslewhite
|
|
|
|
|
Title:
|
|
Chief Executive Officer
|
The Advisory Board Company (MM) (NASDAQ:ABCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
The Advisory Board Company (MM) (NASDAQ:ABCO)
Historical Stock Chart
From Apr 2023 to Apr 2024